2-((2-ethoxyphenoxy)(phenyl)methyl)-4-nitrosomorpholine
AssigneeAxsome Therapeutics, Inc.
InventorsHerriot Tabuteau, Karen L. TenHuisen, Patrick O’Hara, Ranjan Banerjee, Jesus Juarez-Brambila
Life of this patent
Estimating the term…
Abstract
2-((2-ethoxyphenoxy) (phenyl)methyl)-4-nitrosomorpholine is useful for analysis of a pharmaceutical composition. Also disclosed herein are methods of determining the quality of pharmaceutical compositions, and dosage forms comprising a reduced level of 2-((2-ethoxyphenoxy) (phenyl)methyl)-4-nitrosomorpholine. Therapeutic uses of the pharmaceutical compositions and dosage forms are also described herein.
Claims21
(canceled)
A dosage form comprising reboxetine, or a pharmaceutically acceptable salt thereof, and less than 13 ppm of a compound represented by a formula:
A dosage form comprising about 6.5 mg of reboxetine mesylate and less than 13 ppm of a compound represented by a formula:
Dependencies are inferred from the claim text.